Shouxiangu(SH:603896) Zheng Quan Zhi Xing·2025-07-02 16:15Core Viewpoint - The announcement details the conversion results and share changes related to the "Shou 22 Convertible Bonds" issued by Zhejiang Shouxiangu Pharmaceutical Co., Ltd, highlighting the bond's issuance, conversion period, and adjustments to the conversion price due to equity distributions [1][2][3]. Group 1: Bond Issuance and Trading - The company issued 3.98 million convertible bonds with a face value of 100 yuan each, totaling 398 million yuan, approved by the China Securities Regulatory Commission [1]. - The bonds began trading on the Shanghai Stock Exchange on December 12, 2022, under the name "Shou 22 Convertible Bonds" with the code "113660" [1]. Group 2: Conversion Period and Price Adjustments - The conversion period for the bonds is from May 23, 2023, to November 16, 2028, with the initial conversion price set at 38.08 yuan per share [1]. - The conversion price was adjusted to 37.65 yuan per share on July 4, 2023, and will further adjust to 37.27 yuan on June 20, 2024, and to 36.84 yuan on June 6, 2025, due to equity distributions [1][2]. Group 3: Conversion Status - As of June 30, 2025, the total amount converted from the "Shou 22 Convertible Bonds" is 311,000 yuan, representing 0.0781% of the total issuance, resulting in 8,150 shares, which is 0.0041% of the company's total shares before conversion [2][3]. - The amount of unconverted bonds as of June 30, 2025, is 397.689 million yuan, accounting for 99.92% of the total issuance [3][4]. Group 4: Share Capital Changes - The total share capital before the conversion was 198,243,858 shares, which increased to 198,243,911 shares after the conversion of 53 shares [4].